Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:41 PM
Ignite Modification Date:
2025-12-24 @ 4:41 PM
NCT ID:
NCT05141266
Eligibility Criteria:
Inclusion Criteria:
* Adult (≥18 years)
* English speaking
* Not receiving cancer treatment
* Who have a positive opioid misuse screen on the POMI will be eligible to learn about this study
Exclusion Criteria:
* Are pregnant (given potential pre/post-natal opioid use complications among pregnant women/offspring
* Can-not provide collateral contact information for ≥2 contact persons (to ensure consistent contact/follow up)
* Do not have a reliable land line or mobile phone to be contacted by study staff
* Are filling only buprenorphine (given some formulations are not indicated for pain)
* Plan to leave the area for an extended period of time in the next 6 months
* Have had a psychotic and/or manic episode in the last 30 days (before consent, patients will be asked to screen for psychosis
* Do not provide permission to access their state prescription drug monitoring data.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05141266
Study Brief:
Protocol Section:
NCT05141266